Holen Sie sich die Stockscreener-App
67.78
2.21%
-1.53
Apogee Therapeutics Inc Aktie (APGE) Neueste Nachrichten
Michael Thomas Henderson Sells 20,000 Shares of Apogee Therapeutics (NASDAQ:APGE) Stock - MarketBeat
What is Apogee Therapeutics Inc. s 5 year growth outlookPortfolio Value Report & Technical Buy Zone Confirmations - mfd.ru
Aug Volume: What is Apogee Therapeutics Inc. s 5 year growth outlookDip Buying & Safe Entry Point Identification - mfd.ru
What’s the beta of Apogee Therapeutics Inc. stockTrade Volume Report & Technical Pattern Alert System - mfd.ru
Apogee Therapeutics touts quarterly-to-biannual AD dosing shift, expands asthma ambitions at conference - MarketBeat
Page not foundAirwhon - MarketBeat
APGE: Quarterly dosing, rapid itch relief, and strong safety set up a 2029 launch to challenge market leaders - TradingView
Aug Breakouts: Can Apogee Therapeutics Inc. stock outperform in a bear marketJuly 2025 Opening Moves & Daily Volume Surge Trade Alerts - mfd.ru
Candriam S.C.A. Invests $5.01 Million in Apogee Therapeutics Inc. $APGE - MarketBeat
Can Apogee Therapeutics Inc. sustain earnings growth2025 Year in Review & Capital Efficient Trade Techniques - mfd.ru
Apogee Therapeutics stock hits 52-week high at 62.24 USD By Investing.com - Investing.com South Africa
Apogee Therapeutics stock hits 52-week high at 62.24 USD - Investing.com
Smart Money: Should I set a stop loss on Lichen International LimitedEarnings Growth Summary & Weekly Top Gainers Alerts - baoquankhu1.vn
Trading the Move, Not the Narrative: (APGE) Edition - Stock Traders Daily
Portfolio Update: What is Apogee Therapeutics Incs 5 year growth outlook2025 Sector Review & Fast Moving Trade Plans - baoquankhu1.vn
Apogee Therapeutics to Participate at the Guggenheim Emerging Outlook: Biotech Summit 2026 - The Manila Times
Apogee Therapeutics CMO sells $361,860 in shares By Investing.com - Investing.com Australia
Insider Selling: Apogee Therapeutics (NASDAQ:APGE) Insider Sells 5,500 Shares of Stock - MarketBeat
Insider Sell: Jane Henderson Sells 2,000 Shares of Apogee Therap - GuruFocus
Apogee Therapeutics CMO sells $361,860 in shares - Investing.com
Jefferies lowers Apogee Therapeutics stock price target on OX40 concerns By Investing.com - Investing.com Canada
Jefferies lowers Apogee Therapeutics stock price target on OX40 concerns - Investing.com
What drives Apogee Therapeutics Inc.’s stock priceEarnings Overview Summary & Low Risk Entry Point Tips - mfd.ru
Fairmount Funds Management LLC Increases Stake in Apogee Therape - GuruFocus
Aug Gainers: Can Apogee Therapeutics Inc stock outperform in a bear marketWeekly Stock Recap & Long-Term Growth Stock Strategies - baoquankhu1.vn
Exane Asset Management Invests $2.05 Million in Apogee Therapeutics Inc. $APGE - MarketBeat
Apogee Therapeutics, Inc. (APGE) Stock Analysis: Unveiling A 49.24% Upside In Biotech - DirectorsTalk Interviews
Does Apogee Therapeutics Inc. meet Warren Buffett’s criteriaEntry Point & Consistent Return Investment Signals - mfd.ru
(APGE) Volatility Zones as Tactical Triggers - Stock Traders Daily
Apogee Therapeutics Inc. (NASDAQ:APGE) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Aug Shorts: What are TrueBlue Incs growth leversGap Down & Real-Time Chart Pattern Alerts - baoquankhu1.vn
Sanofi (SNY) Phase III Data Sparks Attention in Atopic Dermatitis Space - GuruFocus
Promising Biotech Stocks To ResearchJanuary 24th - MarketBeat
Aug Breakouts: Whats the RSI of Adicet Bio Inc stockPrice Action & Precise Swing Trade Entry Alerts - baoquankhu1.vn
Fairmount Healthcare Fund II L.P. sells Apogee (APGE) shares for $133.53 million By Investing.com - Investing.com Nigeria
Promising Biotech Stocks Worth WatchingJanuary 23rd - MarketBeat
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Apogee Therapeutics (NASDAQ:APGE) Trading Down 10.2% Following Insider Selling - MarketBeat
Apogee Therapeutics (NASDAQ:APGE) Director Fairmount Funds Management Llc Sells 1,750,000 Shares - MarketBeat
Fairmount Healthcare Fund II L.P. sells Apogee (APGE) shares for $133.53 million - Investing.com
Apogee Therapeutics stock downgraded by RBC Capital on valuation concerns By Investing.com - Investing.com Nigeria
Apogee Therapeutics stock downgraded by RBC Capital on valuation concerns - Investing.com India
RBC Downgrades Apogee Therapeutics to Sector Perform From Outperform, Raises Price Target to $83 From $70, Keeps Speculative Risk - marketscreener.com
Apogee Therapeutics: 2026 Inflection Point In Immunology (NASDAQ:APGE) - Seeking Alpha
Apogee Therapeutics, Inc. (APGE) Stock Analysis: A Biotech Gem with a 27.70% Upside Potential - DirectorsTalk Interviews
Bear Alert: Whats the beta of Apogee Therapeutics Inc stock2025 Analyst Calls & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
CEO Michael Henderson Sells 20,000 Shares of Apogee Therapeutics Inc (APGE) - GuruFocus
Apogee Therapeutics CEO Henderson sells $1.6m in stock By Investing.com - Investing.com Nigeria
Apogee Therapeutics (NASDAQ:APGE) CEO Michael Thomas Henderson Sells 20,000 Shares - MarketBeat
Apogee Therapeutics CEO Henderson sells $1.6m in stock - Investing.com
Price-Driven Insight from (APGE) for Rule-Based Strategy - Stock Traders Daily
1.12%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):